HDAC inhibitors for the treatment of diabetic peripheral neuropathy

• 1. 用于癌症治疗的包含HDAC抑制剂、LAG-3抑制剂和PD-1抑制剂或PD-L1抑制剂的组合 [P] . 中国专利： CN112055589A . 2020-12-08
• 2. 使用组蛋白脱乙酰基酶HDAC1、HDAC2和/或HDAC3的选择性抑制剂和微管稳定剂的癌症组合治疗 [P] . 中国专利： CN101861151B . 2014.08.13
• 3. HDAC INHIBITORS FOR THE TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY [P] . US2021155593A1 . 2021-05-27

  机译： HDAC抑制剂用于治疗糖尿病外周神经病变

• 4. HDAC INHIBITORS FOR THE TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY [P] . 美国专利： US2019106392A1 . 2019-04-11

  机译： HDAC抑制剂治疗糖尿病性周围神经病变

• 5. HDAC inhibitors for the treatment of diabetic peripheral neuropathy [P] . 美国专利： US10040769B2 . 2018-08-07

  机译： HDAC抑制剂用于治疗糖尿病周围神经病变

• 1. Efficacy evaluation of high-frequency ultrasound in the treatment of diabetic peripheral neuropathy with α-lipoic acid combined with traditional Chinese medicine package treatment [J] . Pei Hu, Guang-Mei Zheng, Zheng-Sen Dong, 海南医科大学学报(英文版) . 2021,第006期
• 2. Efficacy evaluation of high-frequency ultrasound in the treatment of diabetic peripheral neuropathy with α-lipoic acid combined with traditional Chinese medicine package treatment [J] . Pei Hu, Guang-Mei Zheng, Zheng-Sen Dong, 海南医科大学学报（英文版） . 2021,第006期
• 3. PDE5 inhibitors promote recovery of peripheral neuropathy in diabetic mice [J] . Lei Wang, Michael Chopp, Zheng Gang Zhang 中国神经再生研究（英文版） . 2017,第002期
• 4. Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway [J] . Qing-rong Li, Zhuo Wang, Wei Zhou, 中国神经再生研究（英文版） . 2016,第002期
• 5. Treatment of Diabetic Cardiovascular Autonomic, Peripheral and Painful Neuropathy. Focus on the Treatment of Cardiovascular Autonomic Neuropathy with ACE Inhibitors [J] . Didangelos Triantafyllos, Veves Aristidis Current vascular pharmacology . 2020,第2期
• 6. Zinc supplementation alleviates diabetic peripheral neuropathy by inhibiting oxidative stress and upregulating metallothionein in peripheral nerves of diabetic rats [J] . LiuF., MaF., KongG., Biological trace element research . 2014,第2期
• 7. Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review. [J] . Schemmel KE, Padiyara RS, DSouza JJ Journal of diabetes and its complications . 2010,第5期
• 8. COP Analysis in Type 2 Diabetics with Peripheral Diabetic Neuropathy (Open Data May Contribute with Prognosis and Intervention in Early Stages to Reduce a Risk of Falling) [C] . Daissy Carola Toloza, Martha Zequera, Gustavo Castro International Conference on Biomedical and Health Informatics . 2020
• 9. Microphysiological Model with Multiple Fiber Types for Modeling Diabetic Peripheral Neuropathy [D] . Watza, Keith. 2018
• 10. Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor epalrestat [O] . N Hotta, R Kawamori, Y Atsumi, -1
• 11. Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat [O] . Hotta, N, Kawamori, R, Atsumi, Y, 2008

• 1. Treatment of peripheral diabetic neuropathy in Zucker diabetic fatty (ZDF) rats with cariporide [J] . Sergey Lupachyk ,Hanna Shevalye ,Pierre Watcho . 糖尿病（英文） . 2014,第1期
• 2. 组蛋白去乙酰化酶(HDAC)抑制剂在肿瘤治疗领域的进展 [C] . 董梅 ,胡兴胜 ,陈闪闪 . 第六届中国肿瘤内科大会 . 2012
• 3. HDAC抑制剂NK-HDAC-1临床前初步评价及硼酸类HDAC抑制剂的合成 [A] . 郭伟康 . 2013